Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTAW) Equity Average (2019 - 2025)

Historic Equity Average for Strata Critical Medical (SRTAW) over the last 7 years, with Q3 2025 value amounting to $253.0 million.

  • Strata Critical Medical's Equity Average rose 933.6% to $253.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $253.0 million, marking a year-over-year increase of 933.6%. This contributed to the annual value of $228.1 million for FY2024, which is 1032.86% down from last year.
  • According to the latest figures from Q3 2025, Strata Critical Medical's Equity Average is $253.0 million, which was up 933.6% from $221.4 million recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Equity Average registered a high of $294.0 million during Q3 2021, and its lowest value of $6.3 million during Q1 2021.
  • Over the past 5 years, Strata Critical Medical's median Equity Average value was $253.0 million (recorded in 2025), while the average stood at $239.7 million.
  • Per our database at Business Quant, Strata Critical Medical's Equity Average soared by 441197.66% in 2022 and then plummeted by 1354.55% in 2024.
  • Strata Critical Medical's Equity Average (Quarter) stood at $291.3 million in 2021, then decreased by 4.36% to $278.6 million in 2022, then fell by 10.77% to $248.6 million in 2023, then decreased by 8.4% to $227.7 million in 2024, then rose by 11.12% to $253.0 million in 2025.
  • Its last three reported values are $253.0 million in Q3 2025, $221.4 million for Q2 2025, and $220.8 million during Q1 2025.